These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 35071362)

  • 1. Endocan: A Key Player of Cardiovascular Disease.
    Chen J; Jiang L; Yu XH; Hu M; Zhang YK; Liu X; He P; Ouyang X
    Front Cardiovasc Med; 2021; 8():798699. PubMed ID: 35071362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endocan: A novel inflammatory indicator in cardiovascular disease?
    Balta S; Mikhailidis DP; Demirkol S; Ozturk C; Celik T; Iyisoy A
    Atherosclerosis; 2015 Nov; 243(1):339-43. PubMed ID: 26448266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelitis profile in acute heart failure and cardiogenic shock patients: Endocan as a potential novel biomarker and putative therapeutic target.
    Reina-Couto M; Silva-Pereira C; Pereira-Terra P; Quelhas-Santos J; Bessa J; Serrão P; Afonso J; Martins S; Dias CC; Morato M; Guimarães JT; Roncon-Albuquerque R; Paiva JA; Albino-Teixeira A; Sousa T
    Front Physiol; 2022; 13():965611. PubMed ID: 36035482
    [No Abstract]   [Full Text] [Related]  

  • 4. Inflammation-induced increases in plasma endocan levels are associated with endothelial dysfunction in humans in vivo.
    Cox LA; van Eijk LT; Ramakers BP; Dorresteijn MJ; Gerretsen J; Kox M; Pickkers P
    Shock; 2015 Apr; 43(4):322-6. PubMed ID: 25565643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endocan--the new endothelial activation marker independently associated with soluble endothelial adhesion molecules in uraemic patients with cardiovascular disease.
    Pawlak K; Mysliwiec M; Pawlak D
    Clin Biochem; 2015 Apr; 48(6):425-30. PubMed ID: 25617664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of Endocan in Cardiometabolic Disorders.
    Klisic A; Patoulias D
    Metabolites; 2023 May; 13(5):. PubMed ID: 37233681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endocan Concentration in Kidney Transplant Recipients.
    Malyszko J; Koc-Żórawska E; Malyszko JS
    Transplant Proc; 2018; 50(6):1798-1801. PubMed ID: 30056903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endocan, a putative endothelial cell marker, is elevated in preeclampsia, decreased in acute pyelonephritis, and unchanged in other obstetrical syndromes.
    Adekola H; Romero R; Chaemsaithong P; Korzeniewski SJ; Dong Z; Yeo L; Hassan SS; Chaiworapongsa T
    J Matern Fetal Neonatal Med; 2015; 28(14):1621-32. PubMed ID: 25211383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endocan or endothelial cell specific molecule-1 (ESM-1): a potential novel endothelial cell marker and a new target for cancer therapy.
    Sarrazin S; Adam E; Lyon M; Depontieu F; Motte V; Landolfi C; Lortat-Jacob H; Bechard D; Lassalle P; Delehedde M
    Biochim Biophys Acta; 2006 Jan; 1765(1):25-37. PubMed ID: 16168566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship Between Serum Endocan Levels and Other Predictors of Endothelial Dysfunction in Obese Women.
    Mercantepe F; Baydur Sahin S; Cumhur Cure M; Karadag Z
    Angiology; 2023; 74(10):948-957. PubMed ID: 36369649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of arterial blood pressure reduction on endocan and soluble endothelial cell adhesion molecules (CAMs) and CAMs ligands expression in hypertensive patients on Ca-channel blocker therapy.
    Tadzic R; Mihalj M; Vcev A; Ennen J; Tadzic A; Drenjancevic I
    Kidney Blood Press Res; 2013; 37(2-3):103-15. PubMed ID: 23594880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endocan as a marker of endothelial dysfunction in hypertension: a systematic review and meta-analysis.
    Behnoush AH; Khalaji A; Bahiraie P; Alehossein P; Shobeiri P; Peisepar M; Cannavo A
    Hypertens Res; 2023 Oct; 46(10):2388-2399. PubMed ID: 37580451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endocan regulates acute lung inflammation through control of leukocyte diapedesis.
    Gaudet A; Portier L; Prin M; Copin MC; Tsicopoulos A; Mathieu D; Lassalle P; De Freitas Caires N
    J Appl Physiol (1985); 2019 Sep; 127(3):668-678. PubMed ID: 31295063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum Endocan Levels Predict Drug-Eluting Stent Restenosis in Patients with Stable Angina Pectoris.
    Küp A; Toprak C; Bayam E; İzcı S; Uslu A; Çelık M; Balaban İ; Cerşıt S; Barutçu S; Gündoğmuş PD
    Acta Cardiol Sin; 2020 Mar; 36(2):111-117. PubMed ID: 32201461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levels of endothelial cell-specific molecule-1 (ESM-1) in overt hypothyroidisim.
    Gungor A; Palabiyik SS; Bayraktutan Z; Dursun H; Gokkaya N; Bilen A; Bilen H
    Endocr Res; 2016 Nov; 41(4):275-280. PubMed ID: 26906498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endocan Levels and Endothelial Dysfunction in Patients With Sarcoidosis.
    Aciksari G; Kavas M; Atici A; Kul S; Erman H; Yilmaz Y; Demircioglu K; Yalcinkaya E; Kanbay A; Caliskan M
    Angiology; 2018 Nov; 69(10):878-883. PubMed ID: 29747515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increase of endocan, a new marker for inflammation and endothelial dysfunction, in acute kidney injury.
    Gunay M; Mertoglu C
    North Clin Istanb; 2019; 6(2):124-128. PubMed ID: 31297477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Association Between Endocan Levels and Subclinical Atherosclerosis in Patients With Type 2 Diabetes Mellitus.
    Lv Y; Zhang Y; Shi W; Liu J; Li Y; Zhou Z; He Q; Wei S; Liu J; Quan J
    Am J Med Sci; 2017 May; 353(5):433-438. PubMed ID: 28502328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma endocan level and prognosis of immunoglobulin A nephropathy.
    Lee YH; Kim JS; Kim SY; Kim YG; Moon JY; Jeong KH; Lee TW; Ihm CG; Lee SH
    Kidney Res Clin Pract; 2016 Sep; 35(3):152-9. PubMed ID: 27668158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated serum levels of endocan in patients with psoriasis vulgaris: correlations with cardiovascular risk and activity of disease.
    Balta I; Balta S; Demirkol S; Mikhailidis DP; Celik T; Akhan M; Kurt O; Kurt YG; Aydin I; Kilic S
    Br J Dermatol; 2013 Nov; 169(5):1066-70. PubMed ID: 23889284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.